Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study

Archives of Ophthalmology

Volumn 117, Issue 9, 1999, Pages 1161-1173

  Miller, Joan W ^a   Sclimidt Erfurth, Ursula ^b   Sichenberg, Michel ^c   Pournaras, Constantin ^d   Laqua, Horst ^a   Barbazetto, Irene ^b   Zografos, Leonidas ^c   Piguet, Bertrand ^d   Donati, Guy ^a   Lane, Anne Marie ^b   Bimgruber, Reginald ^c   Van Berg, Hubert Den ^d   Andrew Strong, H ^a   Manjuris, Ulrike ^b   Gray, Todd ^c   Fsadni, Mario ^d   Bressler, Neil M ^a   Gragoudas, Evaigeos S ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0032819606     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.9.1161     Document Type: Article

References (34)

1. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992:99:933-943.
2. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640-1642.
3. Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL. Senile macular degeneration: a case-control study. Am JEpidemlol. 1983:118:213-227.
4. Vingerling JR, Dielemans I, Hofma A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995:102:205-210.
5. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials [published correction appears in Arch Ophthalmol. 1992:110:761]. Arch Ophthalmol. 1991:109:1109-1114.
6. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch Ophthalmol. 1994:112:500-509.
7. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol. 1993;111:1200-1209.
8. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1220-1231.
9. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991:109:1232-1241.
10. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol. 1994;112:480-488.
11. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1986:104:503-512.
12. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Arch Ophtha/mol. 1994:112:489-499.
13. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of agerelated macular degeneration. Arch Ophthalmol. 1990:108:825-831.
14. Weishaupt KR, Corner CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Rss. 1976:36: 2326-2329.
15. Zhou CN. Mechanisms of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol B. 1989:3:299-318.
16. Schmidt-Erfurth U, Kasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994;101:1953-1961
17. Schmidt-Erfurth l), Hasan T, Schomacker K, Flotte T, Birngruber R. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers SurgMed. 1995:17:178-188.
18. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995:113:810-818.
19. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin in photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology. 1996:103:427-438.
20. Husain D, Miller JW, Michaud NA, Kennedy AG, Flotte TJ, Gragoudas ES. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology. 1997;104: 1242-1250.
21. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol. 1996; 114:978-985.
22. Richter AM, Waterfield E, Jain AK, et al. Photosensitising potency of structural analogues of benzoporphyrin derviative (BPD) in a mouse tumour model. BrJ Cancer. 1991:63:87-93.
23. Richter AM, Cerruti-Sola S, Sternberg ED, Dolphin D, Levy JG. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J Photochem Photobiol B. 1990:5:231-244.
24. Allison BA, Waterfield E, Richter AM, Levy JG. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 1991:54:709-715.
25. Schmidt-Erfurth U, Bauman W, Gragoudas E, et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology. 1994:101:89-99.
26. Young LH, Howard MA, Hu LK, Kim RY, Gragoudas ES. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Arch Ophthalmol. 1996:114:186-192.
27. Miller JW, Gragoudas ES, Kramer M, Hasan T, Flotte TJ. Photodynamic therapy of experimental choroidal neovascularization using liposomal benzoporphrin derivative. Presented at: The Annual Meeting of the Retina Society; September 29, 1994; Williamsburg, Va.
28. Husain D, Kramer M, Kenney AG, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to seven weeks after treatment. Invest Ophthalmol Vis Sei. In press.
29. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982:94:91 -96.
30. Submacular Surgery Trials Research Group. SSTManual of Procedures. Springfield, Va: National Technical Information Service; 1998. NTIS Accession No. PB98166648.
31. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in agerelated macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol. 1991:109:1242-1257.
32. Schmidt-Erfurth U, Miller JW, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999;117:1177-1187.
33. Dewey D. Corneal and retinal energy density with various laser beam delivery systems and contact lenses. In: Puliafito CA, ed. Ophthalmic Technologies: Proceedings of the Society of Photo-Optical Instrumentation Engineers, Los Angeles, Calif, January 20-25, 1991. Vol 1423. Bellingham, Wash: The International Society for Optical Engineering; 1991:105-116.
34. TAP Study Group. Treatment of subfoveal choroidal neovascularization in agerelated macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. Arch Ophthalmol. In press.